StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a report published on Thursday. The firm issued a hold rating on the stock.

China Pharma Price Performance

China Pharma stock opened at $0.22 on Thursday. China Pharma has a 12 month low of $0.13 and a 12 month high of $0.60. The business’s fifty day simple moving average is $0.20 and its two-hundred day simple moving average is $0.22. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.